NO20071366L - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number: NO20071366L
Authority: NO; Norway
Prior art keywords: chemokine; receptor; chemical connections; binding; ccr5
Prior art date: 2004-09-02

Application number

NO20071366A

Other languages

English (en)

Norwegian (no)

Inventor

Kristjan Gudmundsson

Sharon Davis Boggs

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-02

Filing date

2007-03-14

Publication date

2007-05-31

2007-03-14 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2007-05-31 Publication of NO20071366L publication Critical patent/NO20071366L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Oncology (AREA)
Neurology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Virology (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)

NO20071366A 2004-09-02 2007-03-14 Kjemiske forbindelser NO20071366L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US60674204P	2004-09-02	2004-09-02
US61076504P	2004-09-17	2004-09-17
PCT/US2005/031098 WO2006028896A2 (en)	2004-09-02	2005-08-31	Chemical compounds

Publications (1)

Publication Number	Publication Date
NO20071366L true NO20071366L (no)	2007-05-31

Family

ID=36000724

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20071366A NO20071366L (no)	2004-09-02	2007-03-14	Kjemiske forbindelser
NO20071418A NO20071418L (no)	2004-09-02	2007-03-15	Kjemiske forbindelser.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20071418A NO20071418L (no)	2004-09-02	2007-03-15	Kjemiske forbindelser.

Country Status (16)

Country	Link
US (2)	US20070254910A1 (es)
EP (2)	EP1799671A4 (es)
JP (2)	JP2008511669A (es)
KR (2)	KR20070053313A (es)
AR (2)	AR050302A1 (es)
AU (2)	AU2005282753A1 (es)
BR (1)	BRPI0514881A (es)
CA (2)	CA2578746A1 (es)
IL (1)	IL181419A0 (es)
MA (1)	MA28872B1 (es)
MX (2)	MX2007002679A (es)
NO (2)	NO20071366L (es)
PE (2)	PE20060656A1 (es)
RU (2)	RU2352567C2 (es)
TW (2)	TW200621754A (es)
WO (2)	WO2006026703A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006026703A2 (en) *	2004-09-02	2006-03-09	Smithkline Beecham Corporation	Chemical compounds
EP1984376A4 (en) *	2006-01-25	2009-04-08	Smithkline Beecham Corp	CHEMICAL COMPOUNDS
EP2042503B1 (en)	2006-05-16	2013-01-30	Ono Pharmaceutical Co., Ltd.	Compound having acidic group which may be protected, and use thereof
EP2055705A4 (en)	2006-07-31	2014-08-20	Ono Pharmaceutical Co	COMPOUND WITH A CYCLIC GROUP BOUND BY A SPIRO BINDING THEREOF AND APPLY THEREOF
US7767826B2 (en) *	2007-10-05	2010-08-03	Pharmatech International, Inc.	Process for the synthesis of L-(+)-ergothioneine
WO2009061856A1 (en) *	2007-11-09	2009-05-14	The Salk Instituite For Biological Studies	Non-nucleoside reverse transcriptase inhibitors
CN102675305B (zh) *	2011-03-08	2014-11-12	中国科学院上海药物研究所	一类咪唑并吡啶类化合物及其制备方法和用途
CN103570683B (zh) *	2012-07-30	2018-04-17	中国科学院上海药物研究所	多取代胺类化合物及其制备方法和用途
PT3105218T (pt)	2014-02-13	2019-12-05	Incyte Corp	Ciclopropilaminas como inibidores de lsd1
DK3105226T3 (da)	2014-02-13	2019-10-14	Incyte Corp	Cyclopropylaminer som lsd1-inhibitorer
WO2016007722A1 (en)	2014-07-10	2016-01-14	Incyte Corporation	Triazolopyridines and triazolopyrazines as lsd1 inhibitors
EP3626720A1 (en)	2015-04-03	2020-03-25	Incyte Corporation	Heterocyclic compounds as lsd1 inhibitors
KR102710120B1 (ko)	2015-08-12	2024-09-27	인사이트 홀딩스 코포레이션	Lsd1 저해제의 염
EP3389652B1 (en)	2015-12-14	2022-09-28	X4 Pharmaceuticals, Inc.	Methods for treating cancer
US10953003B2 (en)	2015-12-14	2021-03-23	X4 Pharmaceuticals, Inc.	Methods for treating cancer
CN108602829A (zh) *	2015-12-15	2018-09-28	百时美施贵宝公司	Cxcr4受体拮抗剂
ES2935834T3 (es)	2015-12-22	2023-03-10	X4 Pharmaceuticals Inc	Métodos para tratar enfermedad de inmunodeficiencia
CA3019394A1 (en)	2016-04-08	2017-10-12	X4 Pharmaceuticals, Inc.	Methods for treating cancer
CN109640988A (zh)	2016-06-21	2019-04-16	X4 制药有限公司	Cxcr4抑制剂及其用途
CN109562106B (zh)	2016-06-21	2023-03-21	X4 制药有限公司	Cxcr4抑制剂及其用途
WO2017223243A1 (en)	2016-06-21	2017-12-28	X4 Pharmaceuticals, Inc.	Cxcr4 inhibitors and uses thereof
EP3585387A4 (en) *	2017-02-21	2020-08-12	Emory University	CHEMIOKIN CXCR4 RECEIVER MODULATORS AND THEIR USES
JP7282786B2 (ja) *	2017-09-25	2023-05-29	シージーンテック（スーチョウ，チャイナ）カンパニーリミテッド	Ｃｘｃｒ４阻害剤としてのヘテロアリール化合物、それを用いた組成物及び方法
EP3687540A4 (en) *	2017-09-25	2021-04-21	CGeneTech (Suzhou, China) Co., Ltd.	HETEROARYL COMPOUNDS USED AS CXCR4 INHIBITORS, COMPOSITION AND METHOD OF USE THEREOF
WO2019183133A1 (en)	2018-03-19	2019-09-26	Emory University	Pan-Tropic Entry Inhibitors
US10548889B1 (en)	2018-08-31	2020-02-04	X4 Pharmaceuticals, Inc.	Compositions of CXCR4 inhibitors and methods of preparation and use
US10968200B2 (en)	2018-08-31	2021-04-06	Incyte Corporation	Salts of an LSD1 inhibitor and processes for preparing the same
EP4117662A4 (en)	2020-03-10	2024-04-03	X4 Pharmaceuticals, Inc.	METHODS OF TREATING NEUTROPENIA

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ225152A (en) *	1987-07-17	1990-04-26	Janssen Pharmaceutica Nv	Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
EP1317451B1 (en) *	2000-09-15	2006-08-09	Anormed Inc.	Chemokine receptor binding heterocyclic compounds
WO2002022599A2 (en) *	2000-09-15	2002-03-21	Anormed Inc.	Chemokine receptor binding heterocyclic compounds
BR0113930A (pt) *	2000-09-15	2003-06-24	Anormed Inc	Compostos heterocìclicos de ligação aos receptores de quimiocina
JP2004512336A (ja) *	2000-09-15	2004-04-22	アノーメッド　インコーポレイティド	ケモカインレセプター結合複素環式化合物
IL161784A0 (en) *	2001-12-21	2005-11-20	Anormed Inc	Chemokine receptor binding heterocyclic compounds with enhanced efficacy
EP1613613B1 (en) *	2003-04-11	2021-06-02	Genzyme Corporation	Cxcr4 chemokine receptor binding compounds
WO2006026703A2 (en) *	2004-09-02	2006-03-09	Smithkline Beecham Corporation	Chemical compounds
WO2006036816A2 (en) *	2004-09-24	2006-04-06	Smithkline Beecham Corporation	Chemical compounds
EP1919872A4 (en) *	2005-08-31	2009-08-05	Smithkline Beecham Corp	CHEMICAL COMPOUNDS

2005
- 2005-08-28 WO PCT/US2005/031099 patent/WO2006026703A2/en not_active Ceased
- 2005-08-28 MX MX2007002679A patent/MX2007002679A/es not_active Application Discontinuation
- 2005-08-28 JP JP2007530353A patent/JP2008511669A/ja active Pending
- 2005-08-28 EP EP05815072A patent/EP1799671A4/en not_active Withdrawn
- 2005-08-31 MX MX2007002615A patent/MX2007002615A/es not_active Application Discontinuation
- 2005-08-31 AU AU2005282753A patent/AU2005282753A1/en not_active Abandoned
- 2005-08-31 CA CA002578746A patent/CA2578746A1/en not_active Abandoned
- 2005-08-31 US US11/574,586 patent/US20070254910A1/en not_active Abandoned
- 2005-08-31 WO PCT/US2005/031098 patent/WO2006028896A2/en not_active Ceased
- 2005-08-31 RU RU2007106780/04A patent/RU2352567C2/ru not_active IP Right Cessation
- 2005-08-31 KR KR1020077007549A patent/KR20070053313A/ko not_active Withdrawn
- 2005-08-31 CA CA002579059A patent/CA2579059A1/en not_active Abandoned
- 2005-08-31 EP EP05794929A patent/EP1784185A4/en not_active Withdrawn
- 2005-08-31 AU AU2005279835A patent/AU2005279835A1/en not_active Abandoned
- 2005-08-31 BR BRPI0514881-2A patent/BRPI0514881A/pt not_active IP Right Cessation
- 2005-08-31 KR KR1020077007349A patent/KR20070049682A/ko not_active Withdrawn
- 2005-08-31 US US11/574,583 patent/US20070232615A1/en not_active Abandoned
- 2005-08-31 RU RU2007106779/04A patent/RU2351592C2/ru not_active IP Right Cessation
- 2005-08-31 JP JP2007530352A patent/JP2008511668A/ja active Pending
- 2005-09-01 AR ARP050103665A patent/AR050302A1/es not_active Application Discontinuation
- 2005-09-01 PE PE2005001008A patent/PE20060656A1/es not_active Application Discontinuation
- 2005-09-01 PE PE2005001007A patent/PE20060712A1/es not_active Application Discontinuation
- 2005-09-01 AR ARP050103666A patent/AR051565A1/es not_active Application Discontinuation
- 2005-09-02 TW TW094130018A patent/TW200621754A/zh unknown
- 2005-09-02 TW TW094130013A patent/TW200612921A/zh unknown
2007
- 2007-02-19 IL IL181419A patent/IL181419A0/en unknown
- 2007-03-14 NO NO20071366A patent/NO20071366L/no not_active Application Discontinuation
- 2007-03-15 NO NO20071418A patent/NO20071418L/no not_active Application Discontinuation
- 2007-03-23 MA MA29772A patent/MA28872B1/fr unknown

Also Published As

Publication number	Publication date
AU2005282753A1 (en)	2006-03-16
WO2006028896A3 (en)	2006-04-27
TW200621754A (en)	2006-07-01
AR051565A1 (es)	2007-01-24
RU2351592C2 (ru)	2009-04-10
RU2352567C2 (ru)	2009-04-20
US20070254910A1 (en)	2007-11-01
RU2007106779A (ru)	2008-10-10
AR050302A1 (es)	2006-10-11
MA28872B1 (fr)	2007-09-03
PE20060656A1 (es)	2006-08-24
WO2006026703A2 (en)	2006-03-09
CA2579059A1 (en)	2006-03-16
WO2006026703A3 (en)	2006-10-05
AU2005279835A1 (en)	2006-03-09
JP2008511668A (ja)	2008-04-17
EP1799671A2 (en)	2007-06-27
WO2006026703A8 (en)	2006-05-26
CA2578746A1 (en)	2006-03-09
EP1799671A4 (en)	2009-06-10
NO20071418L (no)	2007-05-31
KR20070049682A (ko)	2007-05-11
BRPI0514881A (pt)	2008-06-24
WO2006028896A2 (en)	2006-03-16
EP1784185A2 (en)	2007-05-16
MX2007002679A (es)	2007-05-16
TW200612921A (en)	2006-05-01
RU2007106780A (ru)	2008-10-10
EP1784185A4 (en)	2009-06-03
US20070232615A1 (en)	2007-10-04
PE20060712A1 (es)	2006-08-24
KR20070053313A (ko)	2007-05-23
IL181419A0 (en)	2007-07-04
JP2008511669A (ja)	2008-04-17
MX2007002615A (es)	2007-04-27

Publication	Publication Date	Title
NO20071366L (no)	2007-05-31	Kjemiske forbindelser
NO20071161L (no)	2007-05-14	Kjemiske forbindelser
TW200738711A (en)	2007-10-16	Chemical compounds
TW200612935A (en)	2006-05-01	Chemical compounds
WO2007022371A3 (en)	2007-11-01	Chemokine receptor binding compounds
NO20070487L (no)	2007-03-05	3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
MA30531B1 (fr)	2009-06-01	Anticorps anti-dll4 et leurs procedes d'utilisation
WO2007027999A3 (en)	2007-10-04	Chemical compounds
NO20070489L (no)	2007-03-07	3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
MA29627B1 (fr)	2008-07-01	Modifications cristallines de la pyraclostrobine
NO20064347L (no)	2006-09-26	Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20085176L (no)	2009-01-28	Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter
NO20082716L (no)	2008-09-19	Sammensetninger og fremgangsmater for fremstilling av en sammensetning
WO2006036816A3 (en)	2006-06-15	Chemical compounds
NO20081013L (no)	2008-04-14	7-substituerte aza-indazoler, sammensetninger inneholdende disse, produksjonsmetode og anvendelse derav
GB2453068A (en)	2009-03-25	Novel hepatocyte-like cells and hepatoblast-like cells derived from hbs cells
TW200519112A (en)	2005-06-16	Tropane derivatives
WO2006076131A3 (en)	2006-09-21	Chemical compounds
WO2006138259A3 (en)	2007-05-18	Chemokine receptor binding compounds
MA28707B1 (fr)	2007-06-01	Utilisation de 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines substituees lors du traitement de nausees et de vomissements
NO20065319L (no)	2007-01-23	Piperidinderivater som modulatorer for kjemokinreseptor CCR5
NO20060955L (no)	2006-02-27	Farmasoytisk sammensetning som er nyttig til stamcellemobilisering
SE0400208D0 (sv)	2004-02-02	Chemical compounds
EA200601894A1 (ru)	2007-02-27	Производные пиперазинилпиперидина в качестве антагонистов хемокинового рецептора
NO20062900L (no)	2006-08-21	Nye forbindelser

Legal Events

Date	Code	Title	Description
2010-03-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application